Skip to main content
OpenTrials
Completed

NCT Number: NCT04963660

Primary Immunodeficiencies in Costa Rican Adults

Primary immunodeficiencies represent a underdiagnosed group of rare diseases which if diagnosed well and in time can be treated in an efficient manner and prevent complications that may affect the quality of patients life in an severe manner. Neither in Costa Rica nor in Central America studies or national registries regarding the prevalence and characterization of primary immunodeficiencies in adult patients exist up to now. This study reflects for the first time the epidemiologic situation of primary immunodeficiencies in a Central American country, characterizing adult patients diagnosed with primary and idiopathic immune disorders treated in two specialized immunodeficiency clinics in Costa Rica.

Completed

Looking for future studies?

Notify Me

Key information

Age range

12 year–100 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Hospital Calderon Guardia

San José, 00000, Costa Rica

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All patients from adult primary immunodeficiency clinics will be included.

Exclusion criteria

  • Patients with HIV
  • Proven secondary immunodeficiencies.

Treatment and study plan

Primary outcomes

  1. Clinical manifestations of all adult patients diagnosed with primary and idiopathic immune defects

    Time frame: 1 year

    Describe the clinical manifestations of all adult patients diagnosed with primary and idiopathic immune defects attended in the primary immunodeficiency clinics of the Hospitals Mexico and Dr. Rafael Ángel Calderón Guardia during the study period.

Secondary outcomes

  1. characterization of immunodeficient patients

    Time frame: 1 year

    Characterize immunodeficient patients using sociodemographic and health variables.

  2. Concordances between clinical manifestations and literature

    Time frame: 1 year

    •Establish concordances between the clinical manifestations of the group of patients under study with those described in the literature according to the different pathologies.

  3. organic complications

    Time frame: 1 year

    Record organic complications secondary to immunodeficiency status.

  4. type and degree of immunodeficiency

    Time frame: 1 year

    Differentiate the type and degree of immunodeficiency of each patient.

  5. pathonges that cause infectious

    Time frame: 1 year

    Report isolated pathogens that cause infectious manifestations in patients.

  6. bacteria present in upper airways

    Time frame: 1 year

    •Report the colonizing bacteria present in the cultures of the upper airways of the patients requested in the initial approach.

Sponsors and collaborators

Lead sponsor

Caja Costarricense de Seguro Social

Other Gov

Registry information

Official study title

CASE SERIES OF PRIMARY IMMUNODEFICIENCIES IN ADULTS DIAGNOSED IN TWO HOSPITALS OF THE TERTIARY LEVEL OF CARE OF THE COSTA RICAN SOCIAL SECURITY Fund, 2017-2018

Important dates

Study start
2018
Primary completion
2019
Study completion
2019
First posted
Jul 15, 2021
Registry last updated
Jul 15, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.